Karyopharm Therapeutics Inc (KPTI)
1.055
-0.04
(-3.21%)
USD |
NASDAQ |
Apr 25, 12:42
Karyopharm Therapeutics Free Cash Flow: -92.72M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -92.72M |
| September 30, 2023 | -100.98M |
| June 30, 2023 | -99.82M |
| March 31, 2023 | -109.27M |
| December 31, 2022 | -149.67M |
| September 30, 2022 | -97.06M |
| June 30, 2022 | -98.61M |
| March 31, 2022 | -119.22M |
| December 31, 2021 | -112.83M |
| September 30, 2021 | -169.35M |
| June 30, 2021 | -183.70M |
| March 31, 2021 | -168.25M |
| December 31, 2020 | -160.38M |
| September 30, 2020 | -169.16M |
| June 30, 2020 | -161.47M |
| March 31, 2020 | -169.38M |
| December 31, 2019 | -191.03M |
| September 30, 2019 | -200.75M |
| June 30, 2019 | -203.30M |
| March 31, 2019 | -193.12M |
| December 31, 2018 | -161.48M |
| Date | Value |
|---|---|
| September 30, 2018 | -117.81M |
| June 30, 2018 | -100.41M |
| March 31, 2018 | -84.10M |
| December 31, 2017 | -73.78M |
| September 30, 2017 | -88.21M |
| June 30, 2017 | -86.79M |
| March 31, 2017 | -85.96M |
| December 31, 2016 | -84.46M |
| September 30, 2016 | -85.32M |
| June 30, 2016 | -90.45M |
| March 31, 2016 | -98.25M |
| December 31, 2015 | -95.44M |
| September 30, 2015 | -87.43M |
| June 30, 2015 | -80.48M |
| March 31, 2015 | -63.99M |
| December 31, 2014 | -54.28M |
| September 30, 2014 | -51.52M |
| June 30, 2014 | -41.93M |
| March 31, 2014 | -35.70M |
| December 31, 2013 | -30.29M |
Free Cash Flow Range, Past 5 Years
-203.30M
Minimum
Jun 2019
-92.72M
Maximum
Dec 2023
-145.10M
Average
-160.38M
Median
Dec 2020
Free Cash Flow Benchmarks
| Geron Corp | -168.57M |
| Arbutus Biopharma Corp | -86.94M |
| Verastem Inc | -86.46M |
| Actinium Pharmaceuticals Inc | -47.49M |
| Chimerix Inc | -69.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.58M |
| Cash from Investing (Quarterly) | 26.84M |
| Cash from Financing (Quarterly) | 0.264M |
| Free Cash Flow Per Share (Quarterly) | -0.1619 |
| Free Cash Flow to Equity (Quarterly) | -18.80M |
| Free Cash Flow to Firm (Quarterly) | -14.89M |
| Free Cash Flow Yield | -76.95% |